Radiation Dose Reduction in Coronary Angiography
This study aims to investigate methods to reduce radiation exposure for patients undergoing coronary angiography.
Ultra low dose fluoroscopic pulse rate
+ Standard low dose fluoroscopic pulse rate
Prevention Study
Summary
Study start date: November 1, 2025
Actual date on which the first participant was enrolled.This study focuses on finding ways to reduce radiation exposure for doctors performing coronary angiography, a procedure that looks at the heart's blood vessels. The goal is to compare two different levels of radiation used during this procedure: a standard pulse rate and an ultra-low pulse rate. The study targets interventional cardiologists who often face radiation as a job hazard and aims to see if using a lower dose can still effectively perform the procedure while minimizing harm. This is important because reducing radiation exposure can protect both the doctors and patients involved, improving overall safety in medical settings. Participants in the study have procedures done using either the ultra-low dose or the standard dose of radiation. This is done randomly to ensure fair comparison. The procedures take place via the right radial artery, which is a common access point for these types of heart tests. Operators wear special devices called radiation dosimeters to measure the amount of radiation they receive. The study will measure both the total radiation exposure and the exposure per individual procedure. It will also look at how much radiation patients receive during these tests, giving a comprehensive view of the potential benefits of using less radiation during coronary angiography.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.338 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Prevention Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
Inclusion Criteria: * Operators using the right radial approach as a primary access site * Patients of any sex and gender. * Patients Age \> 18 years old. * Patients undergoing diagnostic coronary angiogram from in-patient and out-patient settings from the right radial artery approach Exclusion Criteria: * All operators performing cardiac catheterization from an access point other than the right radial artery * All patients undergoing cardiac catheterization from an access point other than the right radial artery
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalGroup II
Active ComparatorStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location